This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Mitragynine
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict SKIP-FOR-NOW MEDIUM
Isolated mitragynine extracts are much more potent per gram than dried leaf — community use of "kratom" via tea / capsule of dried leaf is qualitatively different from chronic high-dose extract use. The whole-leaf use case has a reasonable harm-reduction profile (mild stimulant at low dose, analgesic/sedative at high dose, modest withdrawal at chronic use). Isolated mitragynine + 7-OH-mitragynine extracts shift the risk profile toward opioid dependence + several US deaths from extract-overdose cases. For Dylan with no chronic pain indication, no current case. SKIP-FOR-NOW; less harmful than O-DSMT but in the same general opioid risk class.
▸ Verdict change log
- 2026-06-05 — Initial verdict SKIP-FOR-NOW. (stub)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.